Browse > Article

Long-Term Survival Benefit of the Bronchial Arterial Embolization for Patients Presenting with Non-Traumatic Hemoptysis in a District Emergency Center  

Chon, Song Bin (Department of Emergency Medicine, Seoul National University College of Medicine)
Jung, Sung Koo (Department of Emergency Medicine, Seoul National University College of Medicine)
Kwak, Young Ho (Department of Emergency Medicine, Seoul National University College of Medicine)
Suh, Gil Joon (Department of Emergency Medicine, Seoul National University College of Medicine)
You, Eun Young (Department of Emergency Medicine, Seoul National University Boramae Hospital)
Shin, Sang Do (Department of Emergency Medicine, Seoul National University Boramae Hospital)
Publication Information
Tuberculosis and Respiratory Diseases / v.57, no.2, 2004 , pp. 148-159 More about this Journal
Abstract
Background : This study was conducted to evaluate the survival benefit of the bronchial arterial embolization (BAE) for patients presenting with non-traumatic hemoptysis. Methods : The clinical data were retrospectively collected from the medical records and the Order Communicating Systems (OCS). The information dealing with death was collected from national death certificates. After enrolled patients were divided with two group such as BAE group (patients who were managed with BAE) and non-BAE group (patients who were managed with conservative modality), the survival benefit of BAE was estimated during the observational period of 24 months through using the Kaplan-Meier survival graph and the Cox-proportional hazard regression analysis. Results : The number of total cases was 272. Of these, BAE group involved 63 and non-BAE group involved 209. 69 cases had the malignant pulmonary lesions, 149 cases had non-malignant chronic lung lesion such as the mycobacteria infection, fungus ball, or bronchiectasis (BE), and 54 cases had the other pathologic conditions. For each sub-groups such as 'malignant lung lesion' group, 'non-malignant chronic lung lesion' group as well as about all cases, the adjusted hazard ratios (HRs) of BAE for death was not significantly different compared to the conservative management. But the adjusted HRs as to underlying causes such as 'malignant lung lesion' group and 'the other conditions' group increased significantly compared to 'non-malignant chronic lung lesion' group. Conclusion : There was no significant survival benefit by BAE procedure on survival in patients presenting with non-traumatic hemoptysis.
Keywords
Hemoptysis; Therapeutic embolization; Survival analysis;
Citations & Related Records

Times Cited By SCOPUS : 0
연도 인용수 순위
  • Reference
1 Swanson KL, Johnson CM, Prakash UB, McKusick MA, Andrews JC, Stanson AW. Bronchial artery em bolization : experience with 54 patients. Chest 2002 Mar;121(3):789-95
2 Szidon JP, Fishman AP. Approach to the Pulmonary Patient with Respiratory Signs and Symptoms: Pul monary Diseases and Disorders. 2nd ed. New York:McGraw-Hill, Inc: 1988. pp 346-351
3 Jorge Roig, Laureano Molins, Ramon Orrilos, Josep Gomez, Manuel Gonzalez. Approach to life threatening hemoptysis. Clin Pulm med 2003;10(6):327-335
4 Hirshberg B, Biran I, Glazer M, Kramer MR. Hemoptysis: Etiology, evaluation, and outcome in a tertiary referral hospital. Chest 1997;112(2):440-4
5 Jean-Baptiste E. Clinical assessment and management of massive hemoptysis. Crit Care Med 2000;28 (5):1642-7
6 Uflacker R, Kaemmerer A, Picon PD, Rizzon CF, Neves CM, Oliveira ES, et al. Bronchial artery embolization in the management of hemoptysis: technical aspects and long-term results. Radiology 1985 Dec;157(3):637-44
7 Mal H, Rullon I, Mellot F, Brugiere O, Sleiman C, Menu Y, et al. Immediate and long term results of bronchial artery embolization for life-threatening hemoptysis. Chest 1999;115(4);996-1001
8 Amir M, Khoja. Bronchial Artery Embolization: Life saving therapy for hemoptysis. J Bronchology 2003; 10(1):22-29
9 Nelson JE, Forman M. Hemoptysis in HIV-infected patients. Chest 1996; 110:737-43
10 William Franklin young Jr, Michael W Stava, chapter 63. Hemoptysis. In: Judith E Tintinalli, Gaber D Kelen, J Stephan Stapczynski, editors. Emergency Medicine. 5th ed. New York: McGraw-Hill, Inc: 2000. p474
11 Ryu JS, Song KS, Yong SJ, Lee HL, Chang J, Shin KC, et al. Bronchial Artery Embolization(BAE) for Hemoptysis of Small Amount: A Comparative Study with Conservative Management. Tuber Respir Dis 1997;44(3):629-38
12 Drooz AT, Lewis CA, Allen TE, Citron SJ, Cole PE, Freeman NJ, et al. Quality improvement guidelines for percutaneous transcatheter embolization. J Vasc Interv Radiol 2003; 14(9):S237-42
13 Irawan Susanto. Managing a patient with hemoptysis. J bronchology 2002;9(1):40-45
14 Osaki S, Nakanishi Y, Wataya H, Takayama K, Inoue K, Takaki Y, et al. Prognosis of bronchial artery embolization in the management of hemoptysis. Respiration 2000;67(4):412-16
15 Corder R. Hemoptysis. Emerg Med Clin North Am 2003 May;21(2):421-35
16 Wong ML, Szkup P, Hopley MJ. Percutaneous Em bolotherapy for Life-reatening Hemoptysis. Chest 2002;121:95-102
17 Jesus Ruben Melendez-Torres, Antonio Padua-y-Gabriel, Victor Manuel Velasco-Rodriguez, Veronica Martinez-Ordaz, Olivia Sanchez-Cabral, Raul Cicero-Sabido. Survival after Bronchial artery embolization in massive hemoptysis : Experience in 24 Cases. J Bronchology 2003;10(1):17-21